Freya Biosciences ApS

Private limited companyCVR 41257547København ØActive

Freya Biosciences ApS is a private limited company, based in København Ø, active in manufacture of pharmaceutical preparations, founded in 2020. The company made a loss in both 2024 and 2025, most recently DKK 92.7m. Equity fell to DKK 72m in 2025. 8 other companies in the database are registered at the same address.

PDF report Compare

Key figures · financial year 2025

Gross profit−DKK 14.1m−112.2% vs. 2024

Net profit−DKK 92.7m−8.5% vs. 2024

EquityDKK 72m−44.6% vs. 2024

Employees18latest month from CVR

What has changed

calculated from recorded figures and dates

Financials: 2025 against 2024

The loss grew: from DKK 85.4m to DKK 92.7m (2024 → 2025).
Equity fell 45% (2024 → 2025), to DKK 72m.

Employees

1 more employees than a year earlier: 18 (07/2026) against 17 (07/2025).

Management and owners, last 24 months

New owners registered: Sofinnova Capital X (28/04/2026).
No longer registered as owner: Sofinnova Capital X (27/04/2026).

Registrations, last 24 months

08/06/2026: Share capital changed from 1,175,250 DKK to 1,185,821 DKK
28/04/2026: Share capital changed from 1,168,191 DKK to 1,175,250 DKK
03/12/2025: Share capital changed from 1,085,138 DKK to 1,168,191 DKK

Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.

Financial statements

Financial years 2020–2025 · amounts in DKK thousand

Equity and net profit

EquityNet profit

Financial figures for Freya Biosciences ApS
	2020	2021	2022	2023	2024	2025	Change
Revenue	not stated	0	not stated	not stated	not stated	not stated	–
Gross profit	−577	−5,460	−16,628	−5,366	−6,657	−14,130	−112.2%
Operating profit (EBIT)	−2,118	−22,759	−39,304	−87,287	−91,549	−98,523	−7.6%
Profit before tax	−2,153	−22,889	−39,108	−86,596	−90,934	−98,214	−8%
Net profit	−1,895	−20,406	−32,157	−81,096	−85,434	−92,714	−8.5%
Total assets	17,194	32,367	16,376	81,766	141,431	82,387	−41.7%
Equity	16,761	28,411	−3,745	75,005	130,067	72,025	−44.6%
Liabilities	433	3,955	20,121	6,761	11,364	10,362	−8.8%
Cash and cash equivalents	12,913	24,465	5,115	74,103	133,192	73,547	−44.8%
Average number of employees	–	–	–	14	14	23	+64.3%

Source: annual reports filed with the Danish Business Authority (XBRL). Figures for the company (not the group); change is the latest year against the year before. “–” means the figure is not stated in the annual report. Revenue is not stated for 2020, 2022, 2023, 2024, 2025: smaller companies may omit it, and we do not derive it from other figures.

Download the figures as CSV · free with an account, amounts in whole DKK

Compare with the industry (59 companies)

Gross profitMedian, the industry (59 companies)

Signals from the financial statements

calculated from the 2025 figures

Loss for 6 years in a row
Net result has been negative in 2020–2025.
How is this calculated?
Net result is negative in the two or more latest annual reports in a row.
Equity fell sharply
Equity fell 45% from 2024 to 2025 (DKK 130.1m to DKK 72m).
How is this calculated?
Equity has fallen by at least 30% from the previous annual report, and it was positive the year before.

The signals are rules applied to the figures in the annual reports. They are not an assessment or credit rating of the company. See Data and method.

Annual reports

6 financial years

Annual reports for Freya Biosciences ApS
Financial year	Period	Published	Figures for	Documents
2025	01/01/2025 – 31/12/2025	02/07/2026	The company	PDF not statedXBRL
2024	01/01/2024 – 31/12/2024	07/07/2025	The company	PDF XBRL
2023	01/01/2023 – 31/12/2023	04/07/2024	The company	PDF XBRL
2022	01/01/2022 – 31/12/2022	03/07/2023	The company	PDF XBRL
2021	01/01/2021 – 31/12/2021	06/07/2022	The company	PDF XBRL
2020	23/03/2020 – 31/12/2020	13/07/2021	The company	PDF XBRL

The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.

Employees

monthly figures from CVR

Employees

Position in the industry

59 companies in the database

Comparison with the other companies in manufacture of pharmaceutical preparations based on the latest financial year.

Gross profit−DKK 14.1mNo. 50 of 57

Better than 13% of the companies in the industry

EquityDKK 72mNo. 17 of 59

Better than 72% of the companies in the industry

Number of employees18No. 20 of 59

Better than 67% of the companies in the industry

Industry median: gross profit DKK 2.8m, net profit −DKK 2.2m, equity DKK 5.2m, 10 employees.

Distribution of gross profit for 34 companies in the industry (latest financial year, logarithmic scale). Amber bar: where this company sits.

Compared with similar companies

size, age and company form

Rank among similar companies
Group	Gross profit	Equity
Companies with fewer than 20 employees69,967 companies in the comparison	No. 69,680of 69,742 Better than 0%	No. 2,335of 69,964 Better than 97%
Same industry and fewer than 20 employees37 companies in the comparison	No. 32of 36 Better than 11%	No. 4of 37 Better than 92%
Companies that are between 5 and 14 years old33,688 companies in the comparison	No. 33,533of 33,588 Better than 0%	No. 908of 33,687 Better than 97%
All companies of type ApS66,508 companies in the comparison	No. 66,319of 66,379 Better than 0%	No. 1,531of 66,505 Better than 98%

The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.

Compare with the industry

Manufacture of pharmaceutical preparations

Gross profit

Freya Biosciences ApS−DKK 14.1m
Novo Nordisk A/SDKK 250.3bn
H. Lundbeck A/SDKK 20.4bn

Net profit

Freya Biosciences ApS−DKK 92.7m
Novo Nordisk A/SDKK 102.4bn
H. Lundbeck A/SDKK 3.2bn

Equity

Freya Biosciences ApSDKK 72m
Novo Nordisk A/SDKK 194bn
H. Lundbeck A/SDKK 24.9bn

Employees

Freya Biosciences ApS18
Novo Nordisk A/S27,279
H. Lundbeck A/S2,261

Latest financial year per company. Choose up to three companies from the largest in the industry.

Owners and group

from the Public Ownership Register

Owners

OMX Opportunity Fund I, LLC5%
Danmarks Eksport- og Investeringsfond10%
OMX Ventures Fund I, LLC10%
Sofinnova Capital IX10%
Bill & Melinda Gates Foundation10%
Sofinnova Capital X15%

Freya Biosciences ApS

Management

8 active registrations

Executive management

Executive management at Freya Biosciences ApS
Name	Role	Appointed
Colleen Denise Acosta	CEO	23/03/2020

Board of directors

Board of directors at Freya Biosciences ApS
Name	Role	Appointed
Peter Finsel Bisgaard	Chair of the board	23/03/2020
Henrijette Elsebeth Richter	Board member	12/08/2020
Colleen Denise Acosta	Board member	12/08/2020
Mark Smith	Board member	12/08/2020
Nicholas Haft	Board member	12/08/2020
Claudia Maria Colciago	Board member	20/02/2023
David Lawrence Stern	Board member	30/09/2024

Auditor: EY Godkendt Revisionspartnerselskab
Founders: Peter Finsel Bisgaard, Origem Holding ApS, MBFH Consulting SAS

Former management (3)

Former management at Freya Biosciences ApS
Name	Role	Appointed	Resigned
Thomas Gundelund Rasmussen	Board member	23/03/2020	12/08/2020
Johannes Epeüs Theodoor van Hylckama Vlieg	Board member	23/03/2020	12/08/2020
Randi Rich	Director	07/02/2023	31/08/2023

Signing rule: Selskabet tegnes af bestyrelsens formand i forening med et medlem af bestyrelsen, af bestyrelsens formand i forening med et medlem af direktionen, eller af den samlede bestyrelse

Address and production units

1 active production units

Fruebjergvej 3
2100 København Ø

København Municipality · Postcode 2100

Other companies at the address (8)

Vektor Ejendomme A/SBuying and selling of own real estate
Symbion A/SRenting of commercial property
Synopsys Denmark ApSComputer consultancy and computer facilities management
Clinical-Microbiomics A/SResearch and experimental development on natural sciences and engineering
River Stone Biotech ApSResearch and experimental development on natural sciences and engineering

Production units
Production unit	Address	Industry	Employees	P number
Freya Biosciences ApS	Fruebjergvej 3, 2100 København Ø	Manufacture of pharmaceutical preparations	17	1025687821

Purpose

Selskabets formål er at udvikle og drive virksomhed inden for handel med farmaceutiske produkter og udstyr samt anden i forbindelse hermed stående virksomhed

The purpose is quoted from the register in Danish.

Changes year by year

93 registered events

392020

72021

12022

272023

122024

22025

52026

20265 changesaccounts 1 · capital 2 · ownership 2

02/07AccountsAnnual report for 2025 published
08/06CapitalShare capital changed from 1,175,250 DKK to 1,185,821 DKK
28/04CapitalShare capital changed from 1,168,191 DKK to 1,175,250 DKK
28/04OwnershipSofinnova Capital X registered as owner (15%)
27/04OwnershipSofinnova Capital X is no longer registered as owner

20252 changescapital 1 · accounts 1

03/12CapitalShare capital changed from 1,085,138 DKK to 1,168,191 DKK
07/07AccountsAnnual report for 2024 published

202412 changescapital 2 · management 1 · ownership 8 · accounts 1

30/09CapitalShare capital changed from 974,400 DKK to 1,085,138 DKK
30/09ManagementDavid Lawrence Stern appointed board member
30/09OwnershipBill & Melinda Gates Foundation registered as owner (10%)
30/09OwnershipSofinnova Capital IX registered as owner (10%)
30/09OwnershipOMX Ventures Fund I, LLC registered as owner (10%)
30/09OwnershipSofinnova Capital X registered as owner (20%)
30/09OwnershipCuranthia Holdings ApS is no longer registered as owner
29/09OwnershipSofinnova Capital X is no longer registered as owner
29/09OwnershipSofinnova Capital IX is no longer registered as owner
29/09OwnershipOMX Ventures Fund I, LLC is no longer registered as owner
26/09CapitalShare capital changed from 748,550 DKK to 974,400 DKK
04/07AccountsAnnual report for 2023 published

202327 changescapital 3 · management 3 · accounts 1 · ownership 20

08/12CapitalShare capital changed from 725,021 DKK to 748,550 DKK
31/08ManagementRandi Rich stepped down as director
03/07AccountsAnnual report for 2022 published
07/06CapitalShare capital changed from 687,375 DKK to 725,021 DKK
07/06OwnershipPeter Finsel Bisgaard is no longer registered as owner
07/06OwnershipMBFH Consulting SAS is no longer registered as owner
07/06OwnershipOrigem Holding ApS is no longer registered as owner
01/04OwnershipDanmarks Eksport- og Investeringsfond registered as owner (10%)
01/04OwnershipVÆKSTFONDEN is no longer registered as owner
20/02CapitalShare capital changed from 350,669 DKK to 687,375 DKK
20/02ManagementClaudia Maria Colciago appointed board member
20/02OwnershipOMX Opportunity Fund I, LLC registered as owner (5%)
20/02OwnershipPeter Finsel Bisgaard registered as owner (5%)
20/02OwnershipSofinnova Capital X registered as owner (15%)
20/02OwnershipSofinnova Capital IX registered as owner (15%)
20/02OwnershipOMX Ventures Fund I, LLC registered as owner (15%)
20/02OwnershipMBFH Consulting SAS registered as owner (5%)
20/02OwnershipCuranthia Holdings ApS registered as owner (5%)
20/02OwnershipOrigem Holding ApS registered as owner (5%)
20/02OwnershipVÆKSTFONDEN registered as owner (5%)
19/02OwnershipSofinnova Capital IX is no longer registered as owner
19/02OwnershipOMX Ventures Fund I, LLC is no longer registered as owner
19/02OwnershipPeter Finsel Bisgaard is no longer registered as owner
19/02OwnershipMBFH Consulting SAS is no longer registered as owner
19/02OwnershipCuranthia Holdings ApS is no longer registered as owner
19/02OwnershipOrigem Holding ApS is no longer registered as owner
07/02ManagementRandi Rich appointed director

20221 changeaccounts 1

06/07AccountsAnnual report for 2021 published

20217 changescapital 2 · accounts 1 · ownership 4

04/11CapitalShare capital changed from 300,433 DKK to 350,669 DKK
13/07AccountsAnnual report for 2020 published
12/04CapitalShare capital changed from 252,172 DKK to 300,433 DKK
12/04OwnershipSofinnova Capital IX registered as owner (20%)
12/04OwnershipOMX Ventures Fund I, LLC registered as owner (20%)
11/04OwnershipSofinnova Capital IX is no longer registered as owner
11/04OwnershipOMX Ventures Fund I, LLC is no longer registered as owner

202039 changesaddress 1 · capital 3 · management 10 · ownership 24 · founded 1

08/12AddressMoved to Fruebjergvej 3, 2100 København Ø
12/08CapitalShare capital changed from 179,780 DKK to 252,172 DKK
12/08ManagementHenrijette Elsebeth Richter appointed board member
12/08ManagementColleen Denise Acosta appointed board member
12/08ManagementMark Smith appointed board member
12/08ManagementNicholas Haft appointed board member
12/08ManagementThomas Gundelund Rasmussen stepped down as board member
12/08ManagementJohannes Epeüs Theodoor van Hylckama Vlieg stepped down as board member
12/08OwnershipPeter Finsel Bisgaard registered as owner (10%)
12/08OwnershipSofinnova Capital IX registered as owner (10%)
12/08OwnershipOMX Ventures Fund I, LLC registered as owner (10%)
12/08OwnershipMBFH Consulting SAS registered as owner (10%)
12/08OwnershipCuranthia Holdings ApS registered as owner (10%)
12/08OwnershipOrigem Holding ApS registered as owner (10%)
12/08OwnershipR. Rich Holding ApS is no longer registered as owner
12/08OwnershipABT Consult ApS is no longer registered as owner
11/08OwnershipOrigem Holding ApS is no longer registered as owner
11/08OwnershipMBFH Consulting SAS is no longer registered as owner
11/08OwnershipCuranthia Holdings ApS is no longer registered as owner
11/08OwnershipPeter Finsel Bisgaard is no longer registered as owner
07/08CapitalShare capital changed from 176,830 DKK to 179,780 DKK
19/05CapitalShare capital changed from 90,000 DKK to 176,830 DKK
19/05OwnershipOrigem Holding ApS registered as owner (20%)
19/05OwnershipMBFH Consulting SAS registered as owner (20%)
19/05OwnershipR. Rich Holding ApS registered as owner (5%)
19/05OwnershipCuranthia Holdings ApS registered as owner (20%)
19/05OwnershipABT Consult ApS registered as owner (5%)
19/05OwnershipPeter Finsel Bisgaard registered as owner (20%)
18/05OwnershipOrigem Holding ApS is no longer registered as owner
18/05OwnershipMBFH Consulting SAS is no longer registered as owner
18/05OwnershipPeter Finsel Bisgaard is no longer registered as owner
23/03FoundedRegistered as Freya Biosciences ApS
23/03ManagementPeter Finsel Bisgaard appointed chair of the board
23/03ManagementColleen Denise Acosta appointed ceo
23/03ManagementThomas Gundelund Rasmussen appointed board member
23/03ManagementJohannes Epeüs Theodoor van Hylckama Vlieg appointed board member
23/03OwnershipOrigem Holding ApS registered as owner (33.33%)
23/03OwnershipMBFH Consulting SAS registered as owner (33.33%)
23/03OwnershipPeter Finsel Bisgaard registered as owner (33.33%)

Related companies

Same industry in København

H. Lundbeck A/S2,261 employees
AJ Vaccines A/S499 employees
Tetra Pharm Technologies ApS39 employees
Motilitycount ApS29 employees
Zerion Pharma A/S15 employees
ReproNovo ApS10 employees

See all →

Same people in management

Eupry ApSvia Claudia Maria Colciago
Cerebriu A/Svia Claudia Maria Colciago
Muna Therapeutics ApSvia Henrijette Elsebeth Richter
O2matic ApSvia Claudia Maria Colciago
Ward247 ApSvia Claudia Maria Colciago
de novo foundry ApSvia Thomas Gundelund Rasmussen

Largest in the industry

See all →

Source and updates

The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 24/10/2026. The company is protected against advertising; contact details are not shown, and the data must not be used for marketing.

View in CVR Report a correction